Tag: Sun Pharma
Bayer and Sun Pharma join forces for new brand of Finerenone in India
In a significant development for the Indian healthcare sector, Sun Pharmaceutical Industries Limited and Bayer have announced a collaborative agreement to market and distribute a ... Read More
Sun Pharma secures marketing rights for stroke drug Tyvalzi from Pharmazz
Sun Pharmaceutical Industries Limited has entered into a license agreement with U.S.-based biopharmaceutical company Pharmazz Inc. for the commercialization of the first-in-class innovative drug, Tyvalzi ... Read More
Sun Pharma’s GL0034 yields promising results in two Phase 1 trials
Sun Pharmaceutical Industries has unveiled positive results from two Phase 1 studies assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of GL0034, a novel long-acting GLP-1 ... Read More
Sun Pharma gains Health Canada’s approval for WINLEVI for acne treatment
Sun Pharma Canada, a subsidiary of Sun Pharmaceutical Industries, has secured Health Canada's approval for their pioneering acne treatment, WINLEVI (clascoterone cream 1%). This marks ... Read More
MMP Industries bags packaging order from Sun Pharmaceutical
MMP Industries, a Nagpur-based manufacturer of aluminum powders, aluminum foils, and aluminum conductors, has bagged its first commercial order from Sun Pharmaceutical Industries for the ... Read More
Sun Pharma to acquire Concert Pharmaceuticals to bolster dermatology franchise
India-based Sun Pharmaceutical Industries (Sun Pharma) will acquire US-based Concert Pharmaceuticals for equity consideration of $576 million to strengthen its global dermatology franchise. Concert Pharmaceuticals ... Read More
Sun Pharma launches generic of breast cancer drug Palbociclib in India
Sun Pharmaceutical Industries (Sun Pharma) said that one of its fully-owned subsidiaries has launched the generic version of Pfizer-developed Palbociclib in India for patients with ... Read More
Sun Pharmaceutical gets SEZABY FDA approval for neonatal seizures
Sun Pharmaceutical Industries has secured approval for SEZABY (phenobarbital sodium powder for injection) from the US Food and Drug Administration (FDA) for the treatment of ... Read More
Sun Pharmaceutical subsidiary acquires Alchemee business from Galderma
Sun Pharmaceutical Industries said that its subsidiary Taro Pharmaceutical Industries’ fully-owned subsidiary Taro Pharmaceuticals U.S.A., has acquired Delaware-based Galderma Holdings, Japan-based Proactiv YK, Canada-based The ... Read More
Sun Pharma to settle patent litigation with Celgene for generic Revlimid
Sun Pharmaceutical Industries (Sun Pharma) along with one of its fully-owned subsidiaries has reached an agreement with Celgene, a fully-owned subsidiary of Bristol Myers Squibb, ... Read More